Given GBP5’s complex mechanisms and broad therapeutic implications, future research should prioritize: (i) Dynamic Profiling: Investigating GBP5 expression across varying immune backgrounds, disease stages, and conditions such as tuberculosis and IBD to refine its role as a biomarker. This evidence concerns the gene GBP5 and tuberculosis.